Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor site update to the page. The change does not affect the study content or user interactions.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s revision tag changed from v3.6.2 to v3.6.3, signaling a minor platform/template update.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small update to the page or its template without changes to the study information.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page adds new user-guidance sections and reflects a recruitment status change, including No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study, and standardizes the Intervention/Treatment label. It also updates the page revision to v3.6.0 and removes the older Intervention / Treatment label and Revision: v3.5.5.SummaryDifference0.5%

- Check56 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov record.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing the previous v3.5.3. This is an administrative update to the page's revision metadata and does not modify study content or results.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.